Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition. [PDF]
Chapman IG, Wu X, Veuger S, Jowsey PA.
europepmc +1 more source
Rad51 determines pathway usage in post-replication repair. [PDF]
Meyer D +14 more
europepmc +1 more source
Epacadostat and Olaparib Synergistically Inhibit the Growth of BRCA-Proficient Triple-Negative Breast Cancer by Suppressing the Expression of BRCA1 and RAD51. [PDF]
Huang L +5 more
europepmc +1 more source
The DNA helicase HELQ promotes replication fork reversal in coordination with BRCA2- and FANCD2-mediated repair pathways. [PDF]
Dunbayev Y +10 more
europepmc +1 more source
From mutation to treatment: The dual role of BRCA1 and BRCA2 in gynecological malignancy development and management a systematic review. [PDF]
Georgy DM +6 more
europepmc +1 more source
Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid Series. [PDF]
Ferrandi G +13 more
europepmc +1 more source
BET inhibition disrupts the FOXM1-MYC axis to induce BRCAness and enhance PARP inhibitor response. [PDF]
Fang P +9 more
europepmc +1 more source
PCNA encircling primer/template junctions is eliminated by exchange of RPA for Rad51: implications for the interplay between human DNA damage tolerance pathways. [PDF]
Norris JL +8 more
europepmc +1 more source
The human RAD52 complex undergoes phase separation and facilitates bundling and end-to-end tethering of RAD51 presynaptic filaments. [PDF]
Alshareedah I +6 more
europepmc +1 more source

